Trial intelligence / Profile preview

Curcumin vs Ibuprofen for Exercise-Induced Muscle Damage in Physically Active Women

NCT07785986Completed

Sponsor
Universidad de Valladolid
Start
Aug 2026
Primary completion
Sep 2026
Countries
1
01

Overview

Randomised, double-blind trial of curcumin in exercise-induced muscle damage (EIMD) (3 arms), sponsored by Universidad de Valladolid. Primary endpoint: Exercise-induced muscle damage at 72 hours. Started Aug 2026; status: completed.

02

Drugs

curcumin
03

Conditions

exercise-induced muscle damage (EIMD)

Beyond the preview

Go deeper on NCT07785986.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07785986.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call